Regulatory publishing professionals are adapting to AI-enabled workflows by developing new skills in data interpretation, AI literacy, and regulatory intelligence analysis.
Explore how agentic AI systems are improving regulatory submissions through autonomous workflows while maintaining essential human oversight and quality standards.
Regulatory operations teams are shifting from tactical, manual tasks toward strategic functions as AI platforms automate routine submission work.
DNXT’s AI self-learning feedback system captures user corrections and applies few-shot learning to continuously improve regulatory document processing accuracy over time.
Discover how microservices architecture on Azure eliminates regulatory publishing bottlenecks, reduces submission times by 50%, and ensures compliance scalability for pharmaceutical teams.
Comprehensive enterprise security framework protecting pharmaceutical regulatory data with Azure AD authentication, encrypted credentials, and complete 21 CFR Part 11 audit trails.
Transform regulatory submission workflows with one-click AI cover letter generation that ensures compliance while saving 95% of manual effort.
Discover how AI-powered EDMS features transform pharmaceutical document management with intelligent duplicate detection, automated summarization, and smart classification for faster regulatory submissions.
Transform regulatory operations with automated workflows connecting planning, document management, and eCTD publishing into seamless digital processes.
DNXT validates every PDF against 23 compliance rules for FDA EMA submissions, eliminating technical rejections with automated validation and auto-fix capabilities.
